Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Health Network, Toronto
USWM, LLC (dba US WorldMeds)
Pfizer
AstraZeneca
Pfizer
Dragonfly Therapeutics
Hoffmann-La Roche
ViroMissile, Inc.
Washington University School of Medicine
Tizona Therapeutics, Inc
M.D. Anderson Cancer Center
Adaptimmune
xCures
Daiichi Sankyo
Natera, Inc.
Second Life Therapeutics
Onchilles Pharma Inc
University Health Network, Toronto
Elephas
Novartis
The Netherlands Cancer Institute
Elephas
Inhibrx Biosciences, Inc
University Health Network, Toronto
TScan Therapeutics, Inc.
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Tempus AI
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
British Columbia Cancer Agency
Memgen, Inc.
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Institut Cancerologie de l'Ouest
Sensei Biotherapeutics, Inc.
Incyte Corporation
MacroGenics
Delfi Diagnostics Inc.
Milton S. Hershey Medical Center
Providence Health & Services
Marengo Therapeutics, Inc.
Genentech, Inc.
University of California, San Diego
Compass Therapeutics
UNICANCER
University of Colorado, Denver